AI Terminal
IDOX PLC
Director's Dealing • Mar 22, 2024
7699_dirs_2024-03-22_8121cd6d-1042-4fde-bf18-be8c7f9a2fa7.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 0452I
IDOX PLC
22 March 2024
22 March 2024
Idox plc
("Idox", "the Company" or "the Group")
Director/PDMR Shareholding
Idox plc (AIM: IDOX), a leading supplier of specialist information management software and Geospatial data solutions to the public and asset intensive sectors, announces that, on 21 March 2024, Jonathan Legdon, Chief Operating Officer of the Company, exercised options under the 2019, 2020 and 2021 Idox plc Long Term Incentive Plan over a total of 1,606,102 ordinary shares of 1p each ("Ordinary Shares").
The Company also announces that, on the same day, Mr Legdon sold 760,000 Ordinary Shares at a price of 62.0671p pence per share partially to satisfy current tax liabilities relating to option exercises over Ordinary Shares.
Following this notification, Mr Legdon has a beneficial holding of 846,102 Ordinary Shares (which represents 0.18% of the issued share capital of the Company).
Applications have been made for the 1,606,102 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 27 March 2024.
The total number of Ordinary Shares in issue following Admission will be 459,300,981. Therefore the total number of Ordinary Shares with voting rights in the Company will be 459,300,981.
The above figure of 459,300,981 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
The information below (set out in accordance with the requirements of EU Market Abuse Regulation) provides further detail:
1.
Details of the person discharging managerial responsibilities / person closely associated
a.
Name
Jonathan Legdon
2.
Reason for the notification
a.
Position/status
Chief Operating Officer
b.
Initial notification
/Amendment
Initial Notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.
Name
Idox plc
b.
LEI
213800Z3FE6PWVSUGE70
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
b.
Nature of the transaction
1. Exercise of options over Ordinary Shares
2. Sale of Ordinary Shares.
c.
Price(s) and volume(s)
| Price(s) | Volume(s) | |
| 1. | n/a | 1,439,179 |
| 2. | 62.0671p | 760,000 |
d.
Aggregated information
· Aggregated volume
· Price
| Price(s) | Volume(s) | |
| 1. | n/a | 1,439,179 |
| 2. | 62.0671p | 760,000 |
e.
Date of the transaction
1. 21 March 2024
2. 21 March 2024
f.
Place of the transaction
1. Outside a trading venue
2. London Stock Exchange (XLON); AIM
For further information please contact:
| Idox plc Chris Stone, Non-Executive Chairman David Meaden, Chief Executive Anoop Kang, Chief Financial Officer |
+44 (0) 870 333 7101 |
| Peel Hunt LLP (NOMAD and Broker) Paul Gillam Adam Telling |
+44 (0) 20 7418 8900 |
| MHP Communications Reg Hoare Ollie Hoare Matthew Taylor |
+ 44 (0) 203 128 8793 [email protected] |
About Idox plc
For more information see www.idoxplc.com @Idoxgroup
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFSDVIIFFIS